However, sterile inflammatory conditions, such as obesity and other metabolic syndrome-associated ailments with altered microbiota may exhibit altered or a decreased GLP-1 production and a protective TLR4 signalling, which is seen during intact epithelial barrier integrity and gut microbiota. Here, GLP1R is linked to obesity disorder.